Skip to main content
Log in

Parents as source of pertussis transmission in hospitalized young infants

  • Original Paper
  • Published:
Infection Aims and scope Submit manuscript

Abstract

Purpose

This study was planned to collect evidences of familial pertussis transmission to infants younger than 6 months of age. Understanding the dynamics of transmission of pertussis in families is essential to plan effective prevention strategies that could be integrated in pertussis control.

Methods

The seroprevalence of IgG antibodies to pertussis toxin (PT-IgG) and prolonged cough symptoms were evaluated in parents of 55 infants aged <6 months hospitalized for confirmed pertussis. Parents of 33 infants with lower respiratory tract infection (LRTI) and parents of 57 healthy infants admitted as outpatients for hip ultrasound examination (HE) were enrolled as controls.

Results

Parents of pertussis cases had PT-IgG levels significantly higher as compared to LRTI and HE parents. More than 40 % were compatible as transmitters of pertussis to their babies, since they had a level of PT-IgG ≥ 100 IU/ml, which is considered diagnostic for a recent pertussis episode. Based on serology, the percentage of pertussis cases that had at least one parent as source of infection was 49.1 %. When cough symptoms were taken into account, the percentage of parents putative transmitters of the infection to their infants increased to 56.4 %.

Conclusions

Parents are scarcely aware of the household transmission of pertussis to their newborns. Our study highlights the need to advise parents about the likelihood of transmission to the newborn and to be particularly aware of coughing symptoms in the household. Since infection can be asymptomatic, a serological survey of family members should also be considered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. EUVAC-NET, Pertussis surveillance annual report 2009. http://www.euvac.net/graphics/euvac/pdf/pertussis_2009.pdf. Accessed 23 June 2016.

  2. Zepp F, Heininger U, Mertsola J, Bernatowska E, Guiso N, Roord J, et al. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis. 2011;11:557–70.

    Article  PubMed  Google Scholar 

  3. Fedele G, Cassone A, Ausiello CM. T-cell immune responses to Bordetella pertussis infection and vaccination. Pathog Dis. 2015;7 (pii:ftv051).

  4. Ausiello CM, Cassone A. Acellular pertussis vaccines and pertussis resurgence: revise or replace? MBio. 2014;10(5):e01339–14.

    Article  Google Scholar 

  5. Locht C. Pertussis: where did we go wrong and what can we do about it? J Infect. 2016 (pii: S0163-4453(16)30047-0).

  6. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev. 2005;18:326–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Melvin JA, Scheller EV, Miller JF, Cotter PA. Bordetella pertussis pathogenesis: current and future challenges. Nat Rev Microbiol. 2014;12:274–88.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Yaari E, Yafe-Zimerman Y, Schwartz SB, Slater PE, Shvartzman P, Andoren N, et al. Clinical manifestations of Bordetella pertussis infection in immunized children and young adults. Chest. 1999;115:1254–8.

    Article  CAS  PubMed  Google Scholar 

  9. Tozzi AE, Celentano LP, Ciofi degli Atti ML, Salmaso S. Diagnosis and management of pertussis. CMAJ. 2005;15(172):509–15.

    Article  Google Scholar 

  10. Gonfiantini MV, Carloni E, Gesualdo F, Pandolfi E, Agricola E, Rizzuto E, et al. Epidemiology of pertussis in Italy: disease trends over the last century. Euro Surveill. 2014;19:20921.

    Article  CAS  PubMed  Google Scholar 

  11. Nelson JD. The changing epidemiology of pertussis in young infants. The role of adults as reservoirs of infection. Am J Dis Child. 1978;132:371–3.

    Article  CAS  PubMed  Google Scholar 

  12. Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J. 2005;24:S58–61.

    Article  PubMed  Google Scholar 

  13. Althouse BM, Scarpino SV. Asymptomatic transmission and the resurgence of Bordetella pertussis. BMC Med. 2015;13:146.

    Article  PubMed  PubMed Central  Google Scholar 

  14. de Greeff SC, Mooi FR, Westerhof A, Verbakel JM, Peeters MF, Heuvelman CJ, et al. Pertussis disease burden in the household: how to protect young infants. Clin Infect Dis. 2010;50:1339–45.

    Article  PubMed  Google Scholar 

  15. Wendelboe AM, Hudgens MG, Poole C, Van Rie A. Estimating the role of casual contact from the community in transmission of Bordetella pertussis to young infants. Emerg Themes Epidemiol. 2007;4:15.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Wiley KE, Zuo Y, Macartney KK, McIntyre PB. Sources of pertussis infection in young infants: a review of key evidence informing targeting of the cocoon strategy. Vaccine. 2013;31:618–25.

    Article  CAS  PubMed  Google Scholar 

  17. Giammanco A, Chiarini A, Maple PA, Andrews N, Pebody R, Gay N, et al. European Sero-Epidemiology Network: standardisation of the assay results for pertussis. Vaccine. 2003;22:112–20.

    Article  CAS  PubMed  Google Scholar 

  18. Hallander HO, Andersson M, Gustafsson L, Ljungman M, Netterlid E. Seroprevalence of pertussis antitoxin (anti-PT) in Sweden before and 10 years after the introduction of a universal childhood pertussis vaccination program. APMIS. 2009;117:912–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Palazzo R, Carollo M, Fedele G, Rizzo C, Rota MC, Giammanco A, et al. Evidence of increased circulation of Bordetella pertussis in the Italian adult population from seroprevalence data (2012-2013). J Med Microbiol. 2016 (Epub ahead of print ).

  20. Xing D, Wirsing von König CH, Newland P, Riffelmann M, Meade BD, Corbel M, et al. Characterization of reference materials for human antiserum to pertussis antigens by an international collaborative study. Clin Vaccine Immunol. 2009;16:303–11.

    Article  CAS  PubMed  Google Scholar 

  21. Hallander HO, Ljungman M, Storsaeter J, Gustafsson L. Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination with Bordetella pertussis in young children. APMIS. 2009;117:797–807.

    Article  CAS  PubMed  Google Scholar 

  22. Guiso N, Berbers G, Fry NK, He Q, Riffelmann M, Wirsing von König CH, EU Pertstrain group. What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur J Clin Microbiol Infect Dis. 2011;30:307–12.

    Article  CAS  PubMed  Google Scholar 

  23. ECDC, 2012 Guidance and protocol for the serological diagnosis of human infection with Bordetella pertussis. http://ecdc.europa.eu/en/publications/Publications/bordetella-pertussis-guidance-protocol-serological-diagnosis.pdf. Accessed 23 June 2016.

  24. Italian Ministry of Health http://www.salute.gov.it/portale/documentazione/p6_2_8_3_1.jsp?lingua=italiano&id=20. Accessed 5 Aug 2016.

  25. The Italian Vaccine Coverage Survey Working Group. Childhood vaccination coverage in Italy: results of a seven-region survey. Bull World Health Org. 1994;72:885–95.

    Google Scholar 

  26. Bisgard KM, Pascual FB, Ehresmann KR, Miller CA, Cianfrini C, Jennings CE, et al. Infant pertussis: who was the source? Pediatr Infect Dis J. 2004;23:985–9.

    Article  PubMed  Google Scholar 

  27. Elliott E, McIntyre P, Ridley G, Morris A, Massie J, McEniery J, et al. National study of infants hospitalized with pertussis in the acellular vaccine era. Pediatr Infect Dis J. 2004;23:246–52.

    Article  PubMed  Google Scholar 

  28. Long SS, Welkon CJ, Clark JL. Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology. J Infect Dis. 1990;161:480–6.

    Article  CAS  PubMed  Google Scholar 

  29. Ward JI, Cherry JD, Chang SJ, Partridge S, Keitel W, Edwards K, et al. Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT). Clin Infect Dis. 2006;43:151–7.

    Article  PubMed  Google Scholar 

  30. Crowcroft NS, Booy R, Harrison T, Spicer L, Britto J, Mok Q, et al. Severe and unrecognised: pertussis in UK infants. Arch Dis Child. 2003;88:802–6 erratum in: Arch Dis Child. 2006;91:453.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Warfel JM, Zimmerman LI, Merkel TJ. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci USA. 2014;111:787–92.

    Article  CAS  PubMed  Google Scholar 

  32. Storsaeter J, Hallander H, Farrington CP, Olin P, Möllby R, Miller E. Secondary analyses of the efficacy of two acellular pertussis vaccines evaluated in a Swedish phase III trial. Vaccine. 1990;8:457–61.

    Article  CAS  PubMed  Google Scholar 

  33. Von Linstow ML, Pontoppidan PL, König C-HW, Cherry JD, Hogh B. Evidence of Bordetella pertussis infection in vaccinated 1-year-old Danish children. Eur J Pediatr. 2010;169:1119–22.

    Article  Google Scholar 

  34. Dabrera G, Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, et al. A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012–2013. Clin Infect Dis. 2015;60:333–7.

    Article  CAS  PubMed  Google Scholar 

  35. van den Biggelaar AH, Poolman JT. Predicting future trends in the burden of pertussis in the 21st century: implications for infant pertussis and the success of maternal immunization. Expert Rev Vaccines. 2016;15:69–80.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by Grants from the Italian Ministry of Health, RF-2010-2317709.

The Pertussis Study Group Pasqualina Leone, Ilaria Schiavoni, Gabriele Buttinelli (Department of Infectious, Parasitic and Immuno-mediated Disease, Istituto Superiore di Sanità, Rome, Italy); Michaela Veronika Gonfiantini, Eleonora Agricola, Luisa Russo, Beatrice Ferretti, Ilaria Campagna (Multifactorial Disease and Complex Phenotype Research Area, Bambino Gesù Children’s Hospital, Rome, Italy); Valentina Marcellini (Immunology Area, B-cell physiopathology Unit, Bambino Gesù Children Hospital, Rome, Italy); Carlo Concato (Virology Unit, Bambino Gesù Children’s Hospital, Rome, Italy); Antonella Frassanito, Raffaella Nenna, Greta Di Mattia (Department of Pediatrics, Sapienza University of Rome, Rome, Italy); Caterina Rizzo (National Centre for Epidemiology Surveillance and Health Promotion, Istituto Superiore di Sanità, Rome, Italy).

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Giorgio Fedele.

Ethics declarations

Conflict of interest

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fedele, G., Carollo, M., Palazzo, R. et al. Parents as source of pertussis transmission in hospitalized young infants. Infection 45, 171–178 (2017). https://doi.org/10.1007/s15010-016-0943-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-016-0943-6

Keywords

Navigation